InsidersTradesSigma
Browse the full record of transactions filed by PIERCE GLENN, Director. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Cumulatively, 5 reports have been logged. The latest transaction was disclosed on 13 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Glenn Pierce is a Board Member and Interim CSO at Global Blood Therapeutics, Inc. and Voyager Therapeutics, Inc. He plays a key role in the governance and strategic direction of these companies, bringing his expertise to the board. His involvement is essential for strategic decision-making.